News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alkermes plc (ALKS) Reports Financial Results For The Periods Ended Dec. 31, 2013 And Provides Financial Expectations For 2014


2/27/2014 7:22:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Alkermes plc (NASDAQ: ALKS) today reported financial results for the three- and nine-month periods ended Dec. 31, 2013, reflecting the company’s transition to a Dec. 31 fiscal year-end. The company also provided financial expectations for 2014.

“Our financial results were ahead of expectations and driven by the robust performance of our key commercial portfolio, particularly our atypical antipsychotic franchise and VIVITROL®.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES